Drugs / NRL0706
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01251237 | Mar → Jul 2010 | colorectal cancer | Norgine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NRL0706 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01251237 ↗ |
| Known as | MOVIPREP Orange | “This study is to investigate the tolerability, acceptability, safety and efficacy of a single dose of NRL0706 (MOVIPREP Orange) in subjects without gastrointestinal symptoms...” NCT01251237 ↗ |